Open-label Extension Study of Brazikumab in Crohn's Disease
Clinical trial NCT03961815 · TERMINATED
Trial details
- NCT number
- NCT03961815
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-06
- Primary completion
- 2023-09-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.